Corporate Banner
Satellite Banner
Technology Networks Header
Friday, October 31, 2014
Technology Networks
 
Register | Sign in
Home Page > Latest Webcasts
  Webcasts
Scientific News
Team Discovers How Microbes Build a Powerful Antibiotic
Researchers discovery opens up new avenues of research into thousands of similar molecules.
Nano Ruffles in Brain Matter
Freiburg researchers decipher the role of nanostructures around brain cells in central nervous system function.
Self-Assembly of Layered Membranes
Scientists used self-assembly under controlled conditions to create a membrane consisting of layers with distinctly different structures.
Peptide Mimics as a Drug Target for Ebola
University of Utah researchers create a tool to develop treatments for Ebola using Protein Technologies’s peptide synthesizer.
Misfolded Proteins Clump Together in a Surprising Place
Stowers researchers create new framework for protein aggregation under acute stress.
New Technique Yields Drug, Biomedical Test Results in One Minute
Slug flow microextraction makes it possible to quickly detect the presence of drugs or to monitor certain medical conditions using only a single drop of blood or urine.
New Clues For Early Colorectal Cancer Detection
Study identifies new biomarkers which could help detect colorectal cancer.
New 'Lab-on-a-Chip' Could Revolutionize Early Diagnosis of Cancer
Faster result times, reduced costs, minimal sample demands and better sensitivity of analysis.
First Pictures of BRCA2 Protein Show How it Works to Repair DNA
Researchers purified the protein and used electron microscopy to reveal its structure.
NanoString, Brigham and Women’s Hospital Collaborate
Research collaboration to accelerate translation of genomic discoveries into clinical diagnostics in oncology.
Scroll Up
Scroll Down
Return
Mode of Action Analysis and Biomarker Discovery Using Mass Spectrometry-Based Phosphoproteomics Technologies
Andreas Jenne, CEO, Kinaxo, speaking at European Biomarkers Summit 2011.
Date Posted: Thursday, December 08, 2011
Print Page

For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here



KINAXO Extends Collaboration with Takeda
KINAXO will apply its quantitative phosphoproteomics technology PhosphoScout ® to assist in research of drugs under development at Takeda.
Tuesday, April 05, 2011
Kinaxo Enters in to an Agreement with AstraZeneca
Under the terms of the agreement, Kinaxo will apply its quantitative mass spec technology platform to support one of AstraZeneca’s oncology programs.
Wednesday, January 05, 2011
KINAXO Enters Agreement with Bristol-Myers Squibb Company
KINAXO will apply its chemical proteomics technologies to deconvolute molecular targets of compounds undergoing discovery research at BMS.
Friday, October 15, 2010
Kinaxo Extends its Collaboration with Roche
KINAXO will apply its phosphoproteomics technology PhosphoScout® to support targeted treatment approaches currently under development at Roche.
Wednesday, January 13, 2010
KINAXO and Bayer Vital GmbH Collaborate in Phosphoproteomics Biomarker Identification
KINAXO will apply its PhosphoScout® for the identification of novel biomarkers in a clinical trial conducted by Bayer Vital.
Thursday, October 29, 2009
Kinaxo Contributes its Quantitative Phosphoproteomics Platform to a Drug Efficiency Study
Company receives a grant by the Bavarian Research Foundation to expand applications for its quantitative phosphoproteomics platform.
Thursday, February 26, 2009
 
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv